ACTA2 mRNA expression decreased to 0.45 ± 0.03-fold (HER2-overexpressing MDA-MB231 cells) and 0.64-fold (4T1 mammary carcinoma cells) of controls with ACTA2 shRNA overexpression (Figure 5C and 5F). Here, ACTA2 is linked to breast carcinoma.